Importantly, AD- and neuroinflammation-associated pathologies, including Aß accumulation, increased pTau/Tau ratios, and iNOS expression, were significantly reversed in all brain regions at 72 h of refeeding. The gene discussed is MAPT; the disease is Alzheimer disease.